Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
82,180 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Sep 30, 2026 | Capital Blue Cross | Endovascular Stent Grafts for Disorders of the Thoracic AortaPayerPolicy · CAPBLUE-MP-1.132 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Electromyography and Nerve Conduction StudiesPayerPolicy · CAPBLUE-MP-2.063 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Electromyography (EMG) (Needle and Non-Needle) of the Anal or Urethral SphincterPayerPolicy · CAPBLUE-MP-2.096 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Electrical Bone Growth Stimulation of the Appendicular SkeletonPayerPolicy · CAPBLUE-MP-1.024 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Dynamic Spinal Visualization and Vertebral Motion AnalysisPayerPolicy · CAPBLUE-MP-5.051 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Dental and Oral Surgery Procedures Performed in a FacilityPayerPolicy · CAPBLUE-MP-1.092 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Deep Brain StimulationPayerPolicy · CAPBLUE-MP-1.042 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Cytochrome P450 Genotype Guided Treatment Strategy (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.234 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Cryosurgical Ablation of Primary or Metastatic Liver TumorsPayerPolicy · CAPBLUE-MP-1.121 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Cryoablation of Tumors Located in the Kidney, Lung, Breast, Pancreas, or BonePayerPolicy · CAPBLUE-MP-1.088 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Cosmetic and Reconstructive SurgeryPayerPolicy · CAPBLUE-MP-1.004 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Cooling Devices Used in the Outpatient SettingPayerPolicy · CAPBLUE-MP-6.040 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Computer-Assisted Corneal TopographyPayerPolicy · CAPBLUE-MP-5.062 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Compression Devices for Treatment of Lymphedema and Peripheral Vascular DiseasePayerPolicy · CAPBLUE-MP-6.013 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Cochlear ImplantPayerPolicy · CAPBLUE-MP-1.023 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Closure Devices for Patent Foramen Ovale and Atrial Septal Defects (ASD) (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-1.039 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy) (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.267 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Chromosomal Microarray Testing for the Evaluation of Pregnancy Loss (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-7.028 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Carrier Screening for Genetic Diseases (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.258 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient SettingPayerPolicy · CAPBLUE-MP-2.051 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Blepharoplasty, Repair of Brow Ptosis and Reconstructive Eyelid Surgery (Retired 9/1/2026)PayerPolicy · CAPBLUE-MP-1.003 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Bioimpedance Devices for Detection and Management of LymphedemaPayerPolicy · CAPBLUE-MP-2.190 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Biofeedback for Miscellaneous IndicationsPayerPolicy · CAPBLUE-MP-2.401 | New policy |
|---|
| Sep 30, 2026 | Capital Blue Cross | Biofeedback as a Treatment of Urinary Incontinence in AdultsPayerPolicy · CAPBLUE-MP-2.399 | New policy |
|---|
| Sep 30, 2026 | Capital Blue Cross | Biofeedback as a Treatment of HeadachePayerPolicy · CAPBLUE-MP-2.400 | New policy |
|---|
| Sep 30, 2026 | Capital Blue Cross | Biofeedback as a Treatment of Fecal Incontinence or ConstipationPayerPolicy · CAPBLUE-MP-2.398 | New policy |
|---|
| Sep 30, 2026 | Capital Blue Cross | Biofeedback as a Treatment of Chronic Pain; (Formerly Biofeedback and Neurofeedback Therapy)PayerPolicy · CAPBLUE-MP-2.064 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Balloon Ostial Dilation for the Treatment of Chronic Rhinosinusitis and Recurrent Acute RhinosinusitisPayerPolicy · CAPBLUE-MP-1.119 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | BCR-ABL1 Testing in Chronic Myelogenous Leukemia (CML) and Acute Lymphoblastic Leukemia (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.317 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | APOS Therapy SystemPayerPolicy · CAPBLUE-MP-8.014 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired AnemiasPayerPolicy · CAPBLUE-MP-9.055 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative NeoplasmsPayerPolicy · CAPBLUE-MP-9.056 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Adjunctive Techniques for Screening, Surveillance and Risk Classification of Barrett Esophagus and Esophageal Dysplasia (Retired 7/1/2026)PayerPolicy · CAPBLUE-MP-2.390 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | ActigraphyPayerPolicy · CAPBLUE-MP-2.087 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Ablation of Peripheral Nerves to Treat PainPayerPolicy · CAPBLUE-MP-2.376 | Metadata changed |
|---|
| Sep 30, 2026 | Capital Blue Cross | Abdominoplasty and Panniculectomy (Retired 9/1/2026)PayerPolicy · CAPBLUE-MP-1.012 | Metadata changed |
|---|
| Sep 30, 2026 | BCBS Oklahoma | Testosterone Replacement TherapiesPayerPolicy · BCBSOK-RX501.076 | Retired |
|---|
| Sep 30, 2026 | BCBS Oklahoma | Ranibizumab Injections, Implants and BiosimilarsPayerPolicy · BCBSOK-OTH903.041 | Retired |
|---|
| Sep 30, 2026 | BCBS Oklahoma | Microvolt T-Wave Alternans (MTWA)PayerPolicy · BCBSOK-MED202.006 | Retired |
|---|
| Sep 30, 2026 | BCBS Oklahoma | Levodopa-Carbidopa Enteral Suspension (e.g., Duopa) for the Treatment of Parkinson DiseasePayerPolicy · BCBSOK-RX504.015 | Retired |
|---|
| Sep 30, 2026 | BCBS New Mexico | Testosterone Replacement TherapiesPayerPolicy · BCBSNM-RX501.076 | Retired |
|---|
| Sep 30, 2026 | BCBS New Mexico | Ranibizumab Injections, Implants and BiosimilarsPayerPolicy · BCBSNM-OTH903.041 | Retired |
|---|
| Sep 30, 2026 | BCBS New Mexico | Microvolt T-Wave Alternans (MTWA)PayerPolicy · BCBSNM-MED202.006 | Retired |
|---|
| Sep 30, 2026 | BCBS New Mexico | Levodopa-Carbidopa Enteral Suspension (e.g., Duopa) for the Treatment of Parkinson DiseasePayerPolicy · BCBSNM-RX504.015 | Retired |
|---|
| Sep 30, 2026 | BCBS Montana | Testosterone Replacement TherapiesPayerPolicy · BCBSMT-RX501.076 | Retired |
|---|
| Sep 30, 2026 | BCBS Montana | Microvolt T-Wave Alternans (MTWA)PayerPolicy · BCBSMT-MED202.006 | Retired |
|---|
| Sep 30, 2026 | BCBS Montana | Levodopa-Carbidopa Enteral Suspension (e.g., Duopa) for the Treatment of Parkinson DiseasePayerPolicy · BCBSMT-RX504.015 | Retired |
|---|
| Sep 30, 2026 | BCBS Montana | Ranibizumab Injections, Implants and BiosimilarsPayerPolicy · BCBSMT-OTH903.041 | Retired |
|---|
| Sep 30, 2026 | BCBS Illinois | Microvolt T-Wave Alternans (MTWA)PayerPolicy · BCBSIL-MED202.006 | Retired |
|---|
| Sep 30, 2026 | BCBS Illinois | Levodopa-Carbidopa Enteral Suspension (e.g., Duopa) for the Treatment of Parkinson DiseasePayerPolicy · BCBSIL-RX504.015 | Retired |
|---|